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In bloodless surgery a series of measures has to be implemented to reduce the perioperative need for
transfusion of whole blood or its components. Jehovah's Witness are the most representative group of
patients opting for bloodless surgery as their faith follows strict believes that prohibits receiving blood.
Geriatric patients requiring bloodless surgery are even more delicate and represent a challenge for
surgeons. The physiological response of the over 65 year population to decreased hemoglobin level is
slower and less effective than in young and adult patients.
Herby we describe the perioperative protocol implemented in our surgical Department offered to
geriatric Jehovah's Witness patients. Preoperative optimization of the patients is the key step in the
preparation period. Intraoperative anesthetic and surgical measures are also required along with a strict
postoperative follow-up.
From our experience, bloodless surgery is feasible in the geriatric population as long as it is performed
in specialized centers where a multidisciplinary team is prepared to speciﬁcally manage this scenario.
Rigorous patients selection and preparation are mandatory.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The term ‘bloodless surgery’ refers to a series of measures in the
pre-, peri- and postoperative care of patients that aim to reduce the
need for allogeneic blood transfusion, and improve patient out-
comes in patients refusing blood tranfusion.
In some patients this is not an option but an obligation due to
religious believes.
Jehovah's Witnesses (JW) are a Christian faith that had its
modern beginnings in the 1870s in USA. Presently the number of
Witnesses is about 6.3 million worldwide, having doubled since
1980s [1].ited States of America; ECG,
esthesiologists; ANH, Acute
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under inspiration from God and it is beneﬁcial in every aspect of
life.
Witnesses believe that blood transfusion is prohibited by
Biblical passages such as Acts 15:19e21, which say “Abstain… from
fornication and from what is strangled [unbled meat] and from
blood.”
Although these verses and others are not stated in medical
terms, Witnesses see them as precluding the transfusion of allo-
geneic whole blood and its four chief components (ie, red blood
cells, white cells, platelets, and plasma) [2].
As a rule, Jehovah's Witnesses will accept most medical treat-
ments, surgical procedures and administration of ﬂuids such as
crystalloids, colloids and starch [3]. The treatments that are viewed
as unacceptable are the transfusion of whole blood, packed red
cells, platelets, white cells or plasma [4].
Table 1 [5] shows in details the acceptable and unacceptable
treatments by JW and those that are still debated.
Regarding the use of a patient's own blood in the course of a
medical procedure or therapy, manyWitnesses do not consider this
to conﬂict with Biblical principles provided there is no advance
storage. Witnesses generally consent to blood management tech-
niques and procedures involving temporary diversion of autolo-
gous blood if no allogeneic blood prime is used (eg,.
Table 1
List of treatments accepted and unaccepted by Jehovah's Witness.
Unacceptable procedures
- Transfusion of allogeneic whole blood, RBCs, WBCs, PLTs, or plasma
- Preoperative autologous blood donation (PAD or predeposit)
Acceptable procedures
- Most surgical and anesthesiologic blood conservation measures
- Most diagnostic and therapeutic procedures (e.g., phlebotomy for laboratory
testing, angiographic embolization)
- Synthetic oxygen therapeutics (e.g., perﬂuorochemicals)
- Non-blood volume expanders (e.g., saline, lactated Ringer's, hydroxyethyl
starches)
- Pharmacologic agents that do not contain blood components or fractions such
as
 Drugs to enhance hemostasis (e.g., tranexamic acid, ε-aminocaproic acid,
aprotinin)
 Hematopoietic growth factors and hematinics (e.g., albumin-free EPO, iron)
 Recombinant products (e.g., albumin-free coagulation factors)
 Topical hemostatic agents (e.g., collagen, gelatin-based hemostats, oxidized
cellulose)
Personal decision (Acceptable to some, declined by others)
- Blood cell salvage (intraoperative or postoperative autotransfusion)
- Acute normovolemic hemodilution (ANH)
- Intraoperative autologous blood component sequestrationy (including intra-
operative plateletpheresis, preparation of ﬁbrin gel, PLT gel, PLTrich plasma)
- Cardiopulmonary bypass
- Apheresis
- Hemodialysis
- Plasma-derived fractions (e.g., immune globulins, vaccines, antivenins, albu-
min, cryoprecipitate)
- Hemostatic products containing blood fractions (e.g., recombinant factor
VIIa¶, coagulation factor concentrates, prothrombin complex concentrate,
ﬁbrin glue and/or sealant, hemostatic bandages containing plasma fractions,
thrombin sealants)
- Products containing plasma-derived blood fractions such as human serum
albumin (e.g., some formulations of EPO, streptokinase, G-CSF, vaccines,
recombinant clotting factors, nuclear imaging products)
- Oxygen therapeutics and other products containing a blood cell-derived
fraction, whether from a human or an animal source (e.g., iron
supplements, hematin, interferon alfa-N3 (leukoderived))
- Epidural blood patch
- Blood cell scintigraphy (e.g., radionuclide tagging for localization of bleeding)
- Peripheral blood progenitor cell transplantation (autologous or allogeneic)
- Transplants (organ, marrow, bone)
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request that external equipment be arranged so that continuity is
maintained with their vascular system [2].
The rational behind bloodless surgery is to implement a protocol
for those patients refusing blood product transfusion in order to
allow a risk free surgery.
The problems of the bloodless surgery are magniﬁed in elderly
who require major elective procedures entailing signiﬁcant blood
loss. Elderly compensate with more difﬁculty the blood loss. The
physiological response of the over 65 year population to decreased
hemoglobin level is slower and less effective than in young and
adult patients.
In the present study we present our experience with “bloodless
surgery” in the geriatric Jehovah's Witness population.
2. Methods
2.1. Our protocol
2.1.1. Preadmission
All our patients planned for surgery were seen in the pre-
admission clinic where they were assessed by a member of the
surgical team along side with an anesthetist.
Blood tests, pulmonary function tests, ECG and cardiologist
assessment were performed in order to detect comorbidities and toassign the patients an ASA score to stratify the operative risk and to
achieve a preoperative optimization with respect to blood count
and coagulation function.
A multidisciplinary meeting including surgeons, anesthetists,
oncologists followed by discussion with patients and patients’
relatives was mandatory to carefully evaluate the surgical risk in a
scenario of bloodless surgery.2.1.2. Improve hematopoiesis
All the patients who were planned to have surgery were given a
preoperative dose of Eritropoietin, generally one week before sur-
gery. Erythropoietin is a glycoprotein hormone normally produced
in response to tissue hypoxia. Its function is to increase circulating
red cell mass [6,7]. Typically one to three preoperative doses of
recombinant human erythropoietin were enough to increase the
Hemoglobin level of 1e3 gr/dl.2.1.3. Planning
Careful planning of the surgical procedure is vital. It is extremely
important to establish a multidisciplinary coordination between
the surgical team along with the anesthetists and paramedics
(theatre staff) to discuss in advance the preparation for a blood less
procedure to facilitate blood conservation strategies (e.g. cell
salvage).2.1.4. Intraoperative measures
- Surgical technique: extra care has to be paid to hemostasis.
Diathermy dissection, the use of harmonic scalpel and of
absorbable cellulose or collagens have all been ascribed to
achieve a better blood loss control [1,8,9].
- Anesthetic technique: Controlled hypotension is a well recog-
nized technique whereby the mean arterial pressure is main-
tained at a low level during surgery, to minimize intra-operative
bleeding [1]. We believe that this technique represent a risk for
brain and heart ischemic injuries and may mask or underesti-
mate a source of bleeding, for this reason this is a technic not
used in our practice.
- Autologous blood transfusion: Cell salvage machines can be
used during surgery and are able to collect and ﬁlter blood
removed by suction and in swabs, which can then be given back
to the patient [10]. This is a safe technique with low risk and it is
well accepted by most of Jehovah's Witness as in the procedure
there is no discontinuity in the process of suction, ﬁltering and
reinfusion of the autologous blood.2.1.5. Postoperative measures
- Reducing blood loss: strict postoperative vigilance to early
detect postoperative hemorrhage is mandatory. Postoperative
daily full blood count is advised.
- Increase hemopoiesis: Iron, vitamin B12 and folate should be
adequately supplemented, and recombinant erythropoietin can
be used if necessary. [9,11]2.2. Our experience
From 2008 to May 2014 we have retrospectively reviewed the
paper and electronic notes of all surgical patients operated in our
Department of Surgical Sciences.
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We have identiﬁed 45 patients of Jehovah's Witness faith and of
age >65. Of these 15 were female and 30 male. The age range was
between 65 and 80 with a mean of 69.
The type of operation performed ranged from minor to major
surgery and are showed in Table 2. All of the patients treated un-
derwent the protocol described. The patients who received the
indication for surgery were all operated by the same surgical team
with a long-lasting experience in managing JW surgical patients.
All of the patients were discharged from our department after
an uneventful recovery period. None of them required nor received
blood (or of its components) transfusion.4. Discussion
A patient's rejection of a procedure does not relieve the physi-
cian of the duty to provide other essential and acceptable medical
management or emergency treatment [12]. Based on this principle,
surgeons have the moral duty to offer the same level of surgical
treatment also to patients refusing blood transfusion.
In the scenario where blood components cannot be used as life
saving procedures, transfusion-alternative strategies have to be
implemented. These strategies consist in the use of medical de-
vices, pharmaceutical supports and particular surgical techniques
to overcome the inability to offer traditional treatment.
The objective of such strategies, tailored to each clinical situa-
tion, is to minimize blood loss, optimize autologous blood man-
agement, and enhance hematopoiesis [9].
Recombinant erythropoietin is available in a biosynthetic form
and it is normally used for patients with renal disease at risk for
pure red-cell aplasia. Bloodless surgery adopted this pharmaceu-
tical support to stimulate the hematopoiesis in the preoperative
preparation but also in the postoperative period, where a certain
amount of blood has been lost during surgery. For elective surgery
600 units/kg of erythropoietin administered subcutaneously once a
week for 3 weeks before surgery can increase the hemoglobin level
by 30 g/L or more [13]. In our experience we limited to 1e2 in-
jection preoperatively. Regarding the surgical technique used,
extreme importance is given to hemostasis during and at the end of
the surgical procedure. Ligation tie is preferred to the use of energy
source devices especially on mid and large caliber vessels. Cell
salvagemachines can be used during surgery and are able to collect
and ﬁlter blood removed by suction and in swabs, which can then
be given back to the patient. When these type of devices are used,
two different suction handles are used during the procedure: one
for the suction of dirty ﬂuids that will be discarded and one for the
suction of blood addressed to the ﬁltering and re-transfusionTable 2
The list of procedures performed in the elderly population of Jehovah's
Witness faith.
Intervento Numero
AAA 1
Prostatectomia 6
Resezione del retto 7
Emicolectomia destra 1
Emicolectomia sin 1
Gastrectomia 1
Colecistectomia 1
Nefrectomia 4
Procedure proctologiche minori 3
Tiroidectomia 10
Altre procedure 10machine. This technique is generally accepted by JW patients, as
there is no discontinuity in the circulation device.
Acute normovolemic hemodilution (ANH), in which the blood is
in a continuous circuit with the patient, may provide a workable
alternative [14].
In the speciﬁc case of geriatric patients, extra care has to be
taken considering that the compensation mechanisms to anemia
are slower and less effective [15,16].
It is been demonstrated that the postoperative mortality rises as
the Hb falls [17]. In a large series of postoperative anemic patients
refusing blood transfusion the authors reported a risk of mortality
increasing of 2.5 times for every gram of Hb decrement [15].
In case of need, especially in emergency situation, the physician
in charge may still give blood transfusion after having informed the
ofﬁcial authorities of the life-saving plan and receive a Court order.
It is important to recognize the correct timing to transfer a pa-
tient to a specialized transfusion alternative center if the physician
in not confortable in the management of these patients.
5. Conclusion
Bloodless surgery in geriatric population is safe and feasible in
selected cases and in specialized centers. Physicians with no
experience in managing patients refusing blood components are
advised to transfer these to specialized centers. The implementa-
tion of a speciﬁc “bloodless” surgery protocol is important to
minimize the risk and to offer to these patient the same quality of
care offered to traditional surgery patients.
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